National Genomic Data-Sharing Framework for Inherited Hematological Disorders in Pakistan  

Developing an interoperable framework for responsible genomic data sharing across Pakistani institutions, using inherited hematological disorders to pilot GA4GH standards and strengthen population-specific evidence for variant interpretation.

Background

Genomic testing for inherited hematological disorders is increasingly performed in Pakistan, including testing for hemoglobinopathies, inherited bone marrow failure syndromes, hereditary anemias, and other rare disorders. However, genomic data generated across hospitals, diagnostic laboratories, and research institutions remain largely fragmented, with no established national mechanism for interoperable discovery and sharing.

This limits collaborative variant interpretation, reduces the availability of population-specific genomic evidence, and creates missed opportunities for multicenter research and improved diagnosis. The challenge is compounded by limited access to bioinformatics expertise and the absence of established technical and governance frameworks for responsible genomic data sharing.

This project will use inherited hematological disorders as a practical use case to develop and demonstrate a National Genomic Data-Sharing Framework for Pakistan. The project will begin with a proof of concept using synthetic data between the Armed Forces Bone Marrow Transplant Centre and Children’s Hospital Lahore, allowing technical and governance workflows to be tested safely. It will then progress to appropriately governed real-world genomic data before scaling to additional institutions.

The framework will explore implementation of relevant GA4GH standards and provide a scalable model that can subsequently be extended to other disease areas and connected with international genomic data-sharing initiatives.

 

Ongoing Work

Our participating institutions have generated genomic data from more than 1,000 patients with hematological disorders through targeted gene panels and whole-exome sequencing. Some cases are resolved through the identification of established pathogenic or likely pathogenic variants. However, a substantial proportion remains unresolved, with variants classified as variants of uncertain significance (VUS).

Many of these variants are rare or potentially novel and are not represented in international genomic databases. In the absence of a mechanism for sharing and comparing genomic data within the local population, we currently cannot determine whether the same variant has been observed in other Pakistani patients, whether it occurs repeatedly within particular disease phenotypes, or whether it may represent a population-specific disease-associated variant.

 

 

References

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5. PMID: 25741868; PMCID: PMC4544753. 

Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M; Genome Aggregation Database Consortium; Rehm HL, MacArthur DG, O'Donnell-Luria A. Variant interpretation using population databases: Lessons from gnomAD. Hum Mutat. 2022 Aug;43(8):1012-1030. doi: 10.1002/humu.24309. Epub 2021 Dec 16. PMID: 34859531; PMCID: PMC9160216. 

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27. Erratum in: Nature. 2021 Feb;590(7846):E53. doi: 10.1038/s41586-020-03174-8. Erratum in: Nature. 2021 Sep;597(7874):E3-E4. doi: 10.1038/s41586-021-03758-y. PMID: 32461654; PMCID: PMC7334197. 

Knoppers BM. Framework for responsible sharing of genomic and health-related data. Hugo J. 2014 Dec;8(1):3. doi: 10.1186/s11568-014-0003-1. Epub 2014 Oct 17. PMID: 27090251; PMCID: PMC4685158. 

Dolman L, Page A, Babb L, Freimuth RR, Arachchi H, Bizon C, Brush M, Fiume M, Haendel M, Hansen DP, Milosavljevic A, Patel RY, Pawliczek P, Yates AD, Rehm HL. ClinGen advancing genomic data-sharing standards as a GA4GH driver project. Hum Mutat. 2018 Nov;39(11):1686-1689. doi: 10.1002/humu.23625. PMID: 30311379; PMCID: PMC6188700.

This limitation makes it difficult to prioritise VUS for further investigation, including functional studies, and may delay diagnosis for patients and families. A national data-sharing framework would allow participating institutions to identify recurrent variants, correlate variants with clinical phenotypes, and collectively build evidence for variant interpretation.

Our existing dataset and ongoing diagnostic activities therefore provide a strong foundation for the proposed pilot. The project will build upon these resources to develop a structured and interoperable approach for responsible genomic data discovery and sharing.

Getting involved with the National Genomic Data-Sharing Framework for Inherited Hematological Disorders in Pakistan  

Have questions?

Find out more

Do you have questions about this GIF project, or are you looking to get involved?